Skip to main content
. 2017 Sep 22;61(10):e00900-17. doi: 10.1128/AAC.00900-17

TABLE 5.

Mutations conferring LZD or DMD resistance among clinical XDR-TB isolates

Drug Locus Amino acid substitution MIC (mg/liter) No. of isolates (%)a
LZD rplC Cys154Arg 4–16 2 (40.0)
DMD fbiC Val318Ile 32 2 (50.0)
a

The proportion represents the rate of isolates with mutation among all resistant isolates.